common.study.topics.clinical

The Gut Microbiota in Obsessive-Compulsive Disorder

common.study.values.description

The Gut Microbiota in Obsessive-Compulsive Disorder

This study will examine the gut microbiota and serum inflammatory markers in patients with Obsessive-Compulsive Disorder vs. healthy controls. Phase II of the study will examine the gut microbiota and cytokine levels following 12-weeks of treatment with Selective Serotonin Reuptake Inhibitors (SSRIs).

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - SSRIs

12-weeks of standard SSRi treatment for those interested in Phase II of the study.

participant.views.study.view.additional

participant.views.study.view.scientific-title

A Pilot Study Examining the Gut Microbiota in Patients With Obsessive-Compulsive Disorder vs. Healthy Controls and Following 12-weeks of Open-label Selective Serotonin Reuptake Inhibitors Treatment

common.study.values.clinical-trial-id

NCT02285699

participant.views.study.view.id

YerEkd